CoChat

GLP-1/GLP-1R Signaling Regulates Ovarian PCOS-Associated Granulosa Cells Proliferation and Antiapoptosis by Modification of Forkhead Box Protein O1 Phosphorylation Sites

Open access
Sun, Zhihua, Li, Peiyi, Wang, Xiao, Lai, Shuchang, Qiu, Hong, Chen, Zhi, Hu, Shidi, Yao, Jie, Shen, Jie · 2020 · International Journal of Endocrinology

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Abstract

As the major cause of female anovulatory infertility, polycystic ovary syndrome (PCOS) affects a great proportion of women at childbearing age. Although glucagon-like peptide 1 receptor agonists (GLP-IRAs) show therapeutic effects for PCOS, its target and underlying mechanism remains elusive. In the present study, we identified that, both in vivo and in vitro , GLP-1 functioned as the regulator of proliferation and antiapoptosis of MGCs of follicle in PCOS mouse ovary. Furthermore, forkhead box protein O1 (FoxO1) plays an important role in the courses. Regarding the importance of granulosa cells (GCs) in oocyte development and function, the results from the current study could provide a more detailed illustration on the already known beneficial effects of GLP-1RAs on PCOS and support the future efforts to develop more efficient GLP-1RAs for PCOS treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2020/1484321

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Serological and metabolic features were altered with or without treatment of liraglutide in PCOS model mice compared with vehicle group. The fasting blood glucose (a), serum insulin level (b), and blood testosterone level (c) were measured in serum samples collected from the three groups, PCOS + liraglutide, PCOS, and vehicle on D54 of life. The body weight was measured on D23, D33, D43, and D53 of life (d). The data were expressed as mean ± SEM (N = 10 mice/one group). ∗P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.005.
Figure 1 Serological and metabolic features were altered with or without treatment of liraglutide in PCOS model mice compared with vehicle group. The fasting blood glucose (a), serum insulin level (b), and blood testosterone level (c) were measured in serum samples collected from the three groups, PCOS + liraglutide, PCOS, and vehicle on D54 of life. The body weight was measured on D23, D33, D43, and D53 of life (d). The data were expressed as mean ± SEM (N = 10 mice/one group). ∗P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.005.CC BY · PubMed Central
Figure 2 Ovarian histopathology changed in PCOS model mice with or without treatment of liraglutide. H&E staining of thin sections of ovaries from mice of three groups, PCOS + liraglutide (c, f), PCOS (b, e), and vehicle (a, d). Micrographs were taken at magnifications: ×40, ×100, and scale bars represent 500 μm and 200 μm, respectively. The numbers of cystic follicles (g) and corpora lutea (h) were counted based on the images after staining. The data were expressed as mean ± SEM (N = 10/group). ∗P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.005.
Figure 2 Ovarian histopathology changed in PCOS model mice with or without treatment of liraglutide. H&E staining of thin sections of ovaries from mice of three groups, PCOS + liraglutide (c, f), PCOS (b, e), and vehicle (a, d). Micrographs were taken at magnifications: ×40, ×100, and scale bars represent 500 μm and 200 μm, respectively. The numbers of cystic follicles (g) and corpora lutea (h) were counted based on the images after staining. The data were expressed as mean ± SEM (N = 10/group). ∗P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.005.CC BY · PubMed Central
Figure 3 Proliferation and antiapoptosis of granulosa cells of PCOS mice were promoted by GLP-1 (7-36) in vitro. (a) GCs were isolated from the ovaries of PCOS model mice (day 54 of life) and treated with increasing doses of GLP-1 (7-36) (0, 10, 100, and 1000 nM). Cell viability was measured by CCK-8 assay. (b) Flow cytometry Annexin V-FITC/PI double staining was used to detect the apoptotic rate of PCOS MGCs in control group and GLP-1 (7-36) (10 nM, 100 nM, and 1000 nM) treated for 48 hours. (c) Bcl-2, bax, and beta-actin were detected using their specific antibodies by the Western blot analysis for the PCOS MGCs with or without 100 nM GLP-1 (7-36) interference for 48 hours. Results are expressed in at least three separate experiments. ∗P < 0.05, and ∗∗P < 0.01.
Figure 3 Proliferation and antiapoptosis of granulosa cells of PCOS mice were promoted by GLP-1 (7-36) in vitro. (a) GCs were isolated from the ovaries of PCOS model mice (day 54 of life) and treated with increasing doses of GLP-1 (7-36) (0, 10, 100, and 1000 nM). Cell viability was measured by CCK-8 assay. (b) Flow cytometry Annexin V-FITC/PI double staining was used to detect the apoptotic rate of PCOS MGCs in control group and GLP-1 (7-36) (10 nM, 100 nM, and 1000 nM) treated for 48 hours. (c) Bcl-2, bax, and beta-actin were detected using their specific antibodies by the Western blot analysis for the PCOS MGCs with or without 100 nM GLP-1 (7-36) interference for 48 hours. Results are expressed in at least three separate experiments. ∗P < 0.05, and ∗∗P < 0.01.CC BY · PubMed Central
Figure 4 GLP-1 (7-36) induced phosphorylation of FoxO1 in PCOS ovarian MGCs. The isolated PCOS mice ovarian GCs were pretreated in the presence or absence of 100 nM GLP-1 (7-36) to detect FoxO1, pFoxO1 (Ser 256), and pFoxO1 (ser 391) using their specific antibodies by the Western blot analysis. The experiment was repeated thrice.
Figure 4 GLP-1 (7-36) induced phosphorylation of FoxO1 in PCOS ovarian MGCs. The isolated PCOS mice ovarian GCs were pretreated in the presence or absence of 100 nM GLP-1 (7-36) to detect FoxO1, pFoxO1 (Ser 256), and pFoxO1 (ser 391) using their specific antibodies by the Western blot analysis. The experiment was repeated thrice.CC BY · PubMed Central
Figure 5 GLP-1 (7-36) protected PCOS MGCs by modification of forkhead box protein O1 phosphorylation sites. (a) FoxO1 was detected using their specific antibodies by the Western blot analysis for the PCOS MGCs after transfection. (b) FoxO1, pFoxO1 (ser 256), bcl-2, and bax were detected using their specific antibodies by the Western blot analysis for the PCOS MGCs treated with 100 nM GLP-1 (7-36) for 48 h after transfection as indicated in the figure legends. The experiment was repeated thrice.
Figure 5 GLP-1 (7-36) protected PCOS MGCs by modification of forkhead box protein O1 phosphorylation sites. (a) FoxO1 was detected using their specific antibodies by the Western blot analysis for the PCOS MGCs after transfection. (b) FoxO1, pFoxO1 (ser 256), bcl-2, and bax were detected using their specific antibodies by the Western blot analysis for the PCOS MGCs treated with 100 nM GLP-1 (7-36) for 48 h after transfection as indicated in the figure legends. The experiment was repeated thrice.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 43 references

Research works printed but not linked: 2

  1. 10.1210/mend.16.3.0806 · doi:10.1210/mend.16.3.0806 · Paper page
  2. 2017, American Journal of Cancer Research, 7, 1476

Cited by

See all 37

Metadata

Authors
Sun, Z., Li, P., Wang, X., Lai, S., Qiu, H., Chen, Z., Hu, S., Yao, J., & Shen, J.
Affiliations
  • Third Affiliated Hospital of Southern Medical University (CN)
  • Southern Medical University (CN)
Corresponding author
Shen, Jie
Venue
International Journal of Endocrinology
Publisher
Wiley
Published
2020-06-19
Volume
2020
Pages
1-10
ISSN
  • 1687-8337 (ISSN-L)
  • 1687-8345
OpenAlex
W3036323776
Cited by
37
References
42
Citations by year
2026: 6 · 2025: 13 · 2024: 5 · 2023: 7 · 2022: 3 · 2021: 3
FWCI
2.87
Type
journal article
Language
en
Open access
Locations
  • International Journal of Endocrinology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Natural Science Foundation of Guangdong Province (2018A030313997, A2019186, 2017-Z04-35)
  • Guangdong Medical Science and Technology Research Fund Project (2018A030313997, A2019186, 2017-Z04-35)
  • Science and Technology Program of Panyu District (2018A030313997, A2019186, 2017-Z04-35)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
Keywords
polycystic ovary syndrome, glucagon-like peptide-1, GLP-1 receptor agonists, granulosa cells, FOXO1 phosphorylation, cell proliferation, apoptosis, oogenesis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: GLP-1/GLP-1R Signaling Regulates Ovarian PCOS-Associated Granulosa Cells Proliferation and Antiapoptosis by Modification of Forkhead Box Protein O1 Phosphorylation Sites. https://app.cochat.ai/papers/10.1155/2020/1484321
The paper
Sun, Z., Li, P., Wang, X., Lai, S., Qiu, H., Chen, Z., Hu, S., Yao, J., & Shen, J. (2020). GLP-1/GLP-1R Signaling Regulates Ovarian PCOS-Associated Granulosa Cells Proliferation and Antiapoptosis by Modification of Forkhead Box Protein O1 Phosphorylation Sites. International Journal of Endocrinology. https://doi.org/10.1155/2020/1484321

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.